A major goal of Texas Biologics is to strengthen and expand biomedical translational research at UT Austin. One mechanism to achieve this goal is to provide financial support for projects in biologics discovery and development. We launched the TXBio Pilot Grant Program to foster research across campus.
Current Funding Opportunities
The 2026 TXBio Pilot Grant competition is now open.
We anticipate holding yearly or bi-yearly grant programs. More opportunities will be posted here as available.
For additional funding opportunities, or to leverage your TXBio Pilot Grant funding, see UT's Internal Funding Opportunities.
2025 Pilot Grant Awardees
Peptide and Chemotherapy Conjugate for Treating Pancreatic Cancer
- Eric Anslyn, Ph.D., College of Natural Sciences
- Kyaw Aung, Ph.D., Dell Medical School
- Stefano Tiziani, Ph.D., College of Natural Sciences
- Alfredo Cardenas, Ph.D., College of Natural Sciences
Development of Novel Lipid Nanoparticles Targeting Airway Basal Cells In Vivo for Long-term Genome Editing
- Debadyuti (Rana) Ghosh, Ph.D., College of Pharmacy
AI-Driven Humanization of Uricase for Gout Therapy
- Edward Marcotte, Ph.D., College of Natural Sciences
- Everett Stone, Ph.D., College of Natural Sciences
Focused Ultrasound-Triggered Local Antibody Delivery for Pancreatic Cancer
- Huiliang (Evan) Wang, Ph.D., Cockrell School of Engineering
- Annalee Nguyen, Ph.D., Cockrell School of Engineering
- William Matsui, M.D., Dell Medical School
